NOVARTIS AG

Novartis AG: Organizational Assessment

Novartis AG is one of the world's largest pharmaceutical companies. Global sales for Novartis exceeded US$22 billion in the latest fiscal year report issued by the company for 2000 (Hoover's Online, 2001a).

Novartis operates in 140 countries. The largest concentrations of company operations, however, are in 17 countries. Other than its home country Switzerland, the remaining 16 countries are Argentina, Austria, Canada, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Mexico, Poland, Spain, Sweden, United Kingdom, and United States (Hoover's Online, 2001d).

Novartis has an expansion strategy that emphasizes both internal growth and the acquisition of competing firms for merger with Novartis. The trend toward mergers in the global pharmaceutical industry is significant. Larger companies are better able to reduce costs. The stronger position of larger firms also enables them to deal more effectively with managed-care organizations. Larger companies also generate the resources required to expand research and development

. . .
Some common words found in the essay are:
Hoover's Online, National Bank, Novartis AG, United Nations, Retrieved Internet, Legal Assessment, Cooperation Development, Switzerland Nevertheless, Monetary Fund, Economic Outlook, hoover's online, novartis ag, internet 27 march, international monetary fund, 27 march, retrieved internet, pharmaceutical industry, internet 27, hoover's online 2001d, online 2001d, 27 march 2002, monetary fund, retrieved internet 27, international monetary, pharmaceutical companies,
Approximate Word count = 1104
Approximate Pages = 4 (250 words per page)

More Essays on NOVARTIS AG